Purpose Sarcoidosis is a multi-system disease that often affects ocular structures. The definitive diagnosis of sarcoidosis requires tissue biopsy for confirmation. Conjunctival biopsy is a simple and relatively inexpensive diagnostic tool. This study was undertaken to determine the utility and cost of conjunctival biopsy for the diagnosis of sarcoidosis compared with other diagnostic biopsy sites. Pulmonary involvement is the most common clinical manifestation of the disease. Transbronchial and mediastinal biopsy can be used to establish the diagnosis of sarcoidosis by directing the biopsy to clinically involved tissue. Bronchoalveolar lavage can contribute data supportive of sarcoidosis without a specific tissue diagnosis.2
biopsy is a simple and relatively inexpensive diagnostic tool. This study was undertaken to determine the utility and cost of conjunctival biopsy for the diagnosis of sarcoidosis compared with other diagnostic biopsy sites. Pulmonary involvement is the most common clinical manifestation of the disease. Transbronchial and mediastinal biopsy can be used to establish the diagnosis of sarcoidosis by directing the biopsy to clinically involved tissue. Bronchoalveolar lavage can contribute data supportive of sarcoidosis without a specific tissue diagnosis. 2 Involvement of the eye in sarcoidosis is common?--<> The most common ophthalmological manifestation is anterior segment granulomatous infiltration. Conjunctival biopsy has been described in the literature since the 1950s, with controversy surrounding the utility of performing a 'blind' biopsy?-12 This study was performed to compare the costs of conjunctival biopsy with biopsy of other tissue sites in patients eventually confirmed as having systemic sarcoidosis.
Patients and methods
A retrospective chart review was performed for all patients who had conjunctival biopsy performed at the Mayo Clinic between 1982 and 1995 with the suspected clinical diagnosis of sarcoidosis. Forty-one patients undergOing conjunctival biopsy were diagnosed with sarcoidosis on the basis of a positive tissue biopsy at any site.
Each conjunctival biopsy was performed following a complete ophthalmological evaluation. The biopsy sample size averaged 5 X 3 X 2 mm and was directed towards a suspicious lesion, if any (Table 1) . Topical anaesthetic and subconjunctival infiltration of local anaesthetic into the inferior palpebral conjunctiva was employed. The lower lid was retracted and a strip of the ballooned conjunctiva was excised using Westcott scissors. Local pressure and irrigation with Dacriose solution provided adequate haemostasis. Topical antibiotic was then placed in the inferior fornix. There were no complications or morbidity associated with the procedure. A thin slice of prepared cucumber13 was treated with a drop of glycerol, air dried and used as a flat mount for the biopsy. The tissue on the cucumber was fixed in 10% buffered formalin and processed in the conventional manner. Paraffin-embedded tissue was sectioned at 5 fLm at multiple levels (16) (17) (18) (19) (20) and stained with haematoxylin and eosin (H&E). Two additional unstained sections were subsequently stained with Ziehl-Neelsen stain (for acid fast organisms) and silver methenamine stain (for fungi) if granulomas were found on H&E-stained material.
Results
The diagnosis of sarcoidosis was confirmed on tissue biopsy of any site in 41 patients; of these, the conjunctival biopsy was positive in 21 patients (51%).
Nine nodular conjunctival lesions were subjected to biopsy: 5 were positive for non-caseating granuloma, 1 specimen was a concretion and 3 showed no pathological changes. Chronic non-specific inflammation was found in 6 specimens.
The numbers of non-caseating granulomas in the subepithelial conjunctival tissues ranged from 2 to 6, but were not present at all levels of the section. Stains for acid fast organisms and fungi were negative. Bilateral conjunctival specimens were obtained in 14 of 21 positive biopsies and 17 of 20 negative biopsies. Of the positive biopsy specimens obtained bilaterally, the majority (71 %) were only positive unilaterally ( Table 2) .
Discussion
Many previous studies have examined the usefulness of performing conjunctival biopsy in presumed sarcoidosis, with the percentage of positive biopsy ranging from 27% to 75%.5-12 The first paper exploring the usefulness of conjunctival biopsy was published in 1955 by Crick et aC They performed 28 conjunctival biopsies. Ten patients had known generalised sarcoidosis and eye involvement; 18 patients presented with uveitis or episcleritis suggestive of sarcoidosis. The conjunctival biopsy was 
Non caseating granulomas were found in 8 (53%) of their cases with 'lesions'. All positive biopsies came from African-Americans, so they concluded that patients of this ethnic group were more likely to have sarcoid granulomas in the conjunctiva. Our study included 6 African-Americans and 1 Asian, of whom 4 African Americans (66%) and the 1 Asian patient (100%) had a positive conjunctival biopsy. (In 2 cases the patient's race was not identifiable from the history.)
Comparing conjunctival biopsy with transbronchial biopsy, Spaide and Wardll prospectively studied 47 patients with clinically suspected sarcoidosis. Thirty-four of their patients (72%) were found to have histopathological evidence for sarcoidosis, 40% were positive on conjunctival biopsy and 66% on transbronchial biopsy. The conjunctival biopsy was more likely to be positive in the setting of conjunctival follicles (67%) than with a normal conjunctiva (31 %). It was also more often positive in the setting of any ocular abnormality consistent with sarcoidosis (60% vs 26%). Eighteen of our patients (41%) (10 conjunctival biopsy positive (55%), 8 biopsy negative (44%)) had current or prior ocular involvement consistent with sarcoidosis.
Karcioglu and Brear10 studied 28 patients prospectively with conjunctival biopsy. Seventy-one per cent of the patients with known sarcoidosis had a positive biopsy whereas 29% of the suspected cases had a positive result. None of their patients had the classic 'millet-seed' nodules in the conjunctiva and the biopsy site was not directed. Our cases had a number of different non-specific conjunctival 'lesions' (Table 1) . Only 8 patients (19%) had classic sarcoid nodules (one 'nodule' was pathologically a concretion).
Nichols et al.9 found 55% positive 'blind' conjunctival biopsies in patients with the suspected diagnosis of sarcoidosis. In their study any patient with 'millet-seed' conjunctival nodules was deliberately excluded. The diagnosis of sarcoidosis in all their patients was confirmed with biopsy of another tissue. A key point they made is that conjunctival biopsy should be performed whenever possible on both eyes, since most granulomas were only found unilaterally. Our results concur, in that non-caseating granulomas were found only unilaterally in 71% of those cases in which bilateral biopsy was performed-( Table 2) .
Other tissue sites (transbronchial lung biopsy, bronchoalveolar lavage, mediastinoscopy, node biopsy, etc.) are seldom 100% positive for confirmation of sarcoidosis. A positive tissue biopsy and the stage of sarcoidosis were correlated by Poe et al.,14 who found a 96% positive transbronchial biopsy when lung parenchyma was involved versus a 44% yield without lung involvement. Ohara et al.15 studied transbronchial biopsy in patients with suspected ocular sarcoidosis and found this method to be helpful in 62% of the 60 patients they studied. None of their patients had hilar lymphadenopathy or pulmonary lesions on the chest roentgenogram. After the transbronchial biOpsy, one of their patients had a segmental pneumothorax that healed spontaneously in 3 days. In contrast, conjunctival biopsy is a procedure with minimal risks, and none of the patients in our study had any complications.
Gilman and Wang1 6 found the probability of a positive transbronchial biopsy in stage II sarcoidosis to be 46% per biopsy specimen. Their diagnostic yield increased logarithmically such that the probability of a positive biopsy increased to 90% after four biopsy specimens. Takayama et alY found that step-sectioning (serial sections in transbronchial specimens) increased the positive yield on transbronchial biopsy from 38% to 47% in patients with stage I and disease and from 57% to 82% in stage II. Serial sectioning of the conjunctiva specimen should also be examined. One of our positive cases was initially read as negative, but when reviewed for the purposes of this study was found on additional sectioning to be positive.
Our 21 patients with a positive conjunctival biopsy underwent 19 additional tissue biopsies (90% positive), some pre-dating the conjunctival biopsy and some performed at other institutions. The 20 patients with negative conjunctival biopsies underwent an additional 28 biopsies (71% positive) ( Table 3) . Costs for the conjunctival biopsy performed in the outpatient setting were less expensive than any of the other biopsy procedures (Table 4 ). In fact 10 conjunctival biopsies could be performed for the same cost as one mediastinoscopy. The patients with a positive conjunctival biopsy could have been saved 17 procedures at an estimated cost of $81 350 to $1 121 150 in 1997 dollars. Since our study found 51 % of the patients with pathologically proven sarcoidosis had a positive conjunctival biopsy, this procedure could be performed on anyone meeting the clinical and laboratory criteria for sarcoidosis to spare the additional expense of the more invasive, potentially more complicated biopsies.
In summary, pathological confirmation of sarcoidosis is similar following either conjunctival biopsy or mediastinal biopsy, with both procedures more likely to be positive in more advanced disease states and with increased tissue sampling. The conjunctival biopsy may be positive in approximately 50% of patients with sarcoidosis. The most helpful conjunctival specimen for biopsy purposes is a strip of tissue 8-10 mm long from the inferior conjunctival fornix. The pathologist must step-section the conjunctival specimens as the non- caseating granulomas are not uniformly distributed. Of all the biopsy techniques performed to confirm sarcoidosis, conjunctival biopsy is the least expensive and least complicated. Compared with mediastinoscopy, conjunctival biopsy is one-tenth the cost. Performance of a conjunctival biopsy may save the patient a more costly and complex biopsy procedure while securing the diagnosis of sarcoidosis.
